COVID-19疫情下慢病患儿的药学服务模式  

Facing the COVID-19 Outbreak: Pharmaceutical Care Model for Children with Chronic Disease

作　　者：黄凌斐[1] 杨巨飞[1] 高鹏[1] 王慧娟[1] 朱正怡[1] 倪映华[1] 方罗 HUANG Lingfei;YANG Jufei;GAO Peng;WANG Huijuan;ZHU Zhengyi;NI Yinghua;FANG Luo(Department of Pharmacy,The Children’s Hospital,Zhejiang University School of Medicine,National Clinical Research Center for Child Health,Hangzhou 310052,China)

机构地区：[1]浙江大学医学院附属儿童医院、国家儿童健康与疾病临床医学研究中心药剂科,杭州310052

出　　处：《中国现代应用药学》2020年第5期555-559,共5页Chinese Journal of Modern Applied Pharmacy

基　　金：浙江大学新型冠状病毒肺炎(COVID-19)应急科研专项资金;浙江省151人才工程(方罗);浙江省医坛新秀培养工程(方罗)。

摘　　要：2019年12月我国发生新型冠状病毒感染,儿童、婴幼儿甚至新生儿均有感染病例。此疫情下,如何开展高质量的儿科药学服务、保障患儿安全用药,是目前儿科药师的重点工作。因此,本文基于疫情期间儿童慢病用药特点与特殊需求,结合长期慢病患儿的药学服务经验和疫情期间的实际工作,从慢病患儿新型冠状病毒感染用药资料库的构建、线上线下相结合药学服务的开展、分级药学服务策略的探索等方面归纳相关药学服务模式,以期为特殊时期儿童慢病服务开展提供参考。Since December 2019, an epidemic called coronavirus disease 2019 or COVID-19 quickly spread across China, and a number of pediatric cases have been reported. Facing the COVID-19 outbreak, it is more difficult to provide pharmaceutical care for children with chronic disease. How to reduce the risk of cross-infection while ensuring the safety of medication is a problem that pediatric pharmacists should pay close attention to. Therefore, specific pharmaceutical care model has been carried out in our hospital during this particular period;and the correlative experience is summarized in three aspects: construction of drug database for COVID-19;development of internet pharmaceutical services;and multi-hierarchical pharmaceutical care strategy;and finally to provide a reasonable reference for other healthcare institutions.

关 键 词：新型冠状病毒肺炎 儿童 慢病 药学服务 

分 类 号：R969.3[医药卫生—药理学]